BlackRock Reports Full Year 2024 Diluted EPS of $42.01, or $43.61 as Adjusted; Fourth Quarter 2024 Diluted EPS of $10.63, or $11.93 as Adjusted
Go back to BlackRock Reports Full Year 2024 Diluted EPS of $42.01, or $43.61 as Adjusted; Fourth Quarter 2024 Diluted EPS of $10.63, or $11.93 as Adjusted| BlackRock (NYSE: BLK) | Delayed: 1090.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1090.27 | 52 Week High | $380.30 | |||
| Open | $1090.27 | 52 Week Low | $280.55 | |||
| Day High | $1090.27 | P/E | 64.63 | |||
| Day Low | $1090.27 | EPS | $16.87 | |||
| Volume | 144 | |||||
| BLACKROCK HEALTH SCIENCES TRUST (NYSE: BME) | Delayed: 44.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.53 | 52 Week High | $43.64 | |||
| Open | $44.53 | 52 Week Low | $29.67 | |||
| Day High | $44.53 | P/E | N/A | |||
| Day Low | $44.53 | EPS | $0.00 | |||
| Volume | 408 | |||||
